ABBOTT LABORATORIES Unrecognized Tax Benefits, Increase Resulting from Acquisition
ABBOTT LABORATORIES (ABT) reported Unrecognized Tax Benefits, Increase Resulting from Acquisition of $479.00 million for the 12-month period ending 2017-12-31, per its 10-K filed 2019-02-22.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition · last filed 2019-02-22
- ABBOTT LABORATORIES unrecognized tax benefits, increase resulting from acquisition for fiscal 2017 was $479.00M, a 14.46% decline from fiscal 2016.
- ABBOTT LABORATORIES unrecognized tax benefits, increase resulting from acquisition for fiscal 2016 was $560.00M, a 6.67% decline from fiscal 2015.
- ABBOTT LABORATORIES unrecognized tax benefits, increase resulting from acquisition for fiscal 2015 was $600.00M.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Acquisition 12 month |
|---|---|
| 2017-12-31 | $479.00M 10-K · filed 2019-02-22 |
| 2016-12-31 | $560.00M 10-K · filed 2017-02-17 |
| 2015-12-31 | $600.00M 10-K · filed 2017-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |